Honda, Daisuke
Ohsawa, Isao
Iwanami, Keiichi
Rinno, Hisaki
Tomino, Yasuhiko
Suzuki, Yusuke
Article History
Received: 26 November 2020
Accepted: 4 January 2021
First Online: 5 February 2021
Change Date: 24 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12328-021-01390-x
Compliance with ethical standards
:
: D.H, K.I, H.R, Y.T, and Y.S have no financial conflict of interests to declare. I.O has received honoraria as a speaker/advisor from BioCryst, Shire and Takeda Pharmaceutical Company.